FDA's vaccine chief said another choice in the U.S. may entice at least some vaccine holdouts - whatever their reason - to consider rolling up their sleeves. FOX13
In this photo illustration, a medical syringe is displayed on a screen, and the logo of Novavax in the background.
Novavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company. If the FDA authorizes Novavax as the nation's fourth vaccine, it’s not clear how widely it would be used -- at least right away. Only about 27 million U.S. adults remain unvaccinated. Eventually, Novavax hopes also to become a choice for the millions more who haven’t yet had a booster dose of today’s vaccines. The shots are used elsewhere as a booster, regardless of which vaccine people got originally.
This type of vaccine "we think generates a broad immune response against a broad array of variants," he told the FDA advisory panel.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Novavax Covid-19 Vaccine Faces FDA Advisers’ ScrutinyThe outside panel of experts will vote on whether the shot should be authorized, after the agency found it effective but flagged a safety concern.
Weiterlesen »
FDA advisers meeting on Novavax, a latecomer in COVID-19 vaccine raceA federal advisory committee will vote on whether regulators should authorize a COVID-19 vaccine made by Novavax. From The New York Times.
Weiterlesen »
FDA advisory panel to consider approving fourth COVID-19 vaccine, this one from Maryland's NovavaxDevelopment of the vaccine, from Novavax, a Gaithersburg, Maryland-based company, was started at the same time as others in 2020, but the company struggled to produce its shot in large quantities.
Weiterlesen »
Novavax Covid Vaccine Clears Key Step on Path to FDA Authorization After Committee Endorses the ShotNovavax’s shot would be the fourth Covid vaccine authorized for use in the U.S. The shots use different technology than Pfizer and Moderna.
Weiterlesen »
FDA advisers back Novavax COVID-19 shots as new US optionNovavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company.
Weiterlesen »
Novavax Faces High Stakes FDA Review This Week That Will Decide the Fate of Its Covid Vaccine in the U.S.The Food and Drug Administration’s independent experts will review the safety and effectiveness of Novavax’s Covid vaccine Tuesday. If they endorse the vaccine, the FDA will almost certainly authorize the shot for adults in the U.S. Novavax’s vaccine uses protein technology that is different Pfizer and Moderna’s messenger RNA shots. Novavax was part of the U.S. race to develop a…
Weiterlesen »